Major components and auxiliary factors of the Notch signaling pathway (modified from )
Major components and auxiliary factors of the Notch signaling pathway (modified from [6]). In signal-receiving cells, Notch receptors are first synthesized in the endoplasmic reticulum and then translocated to the Golgi apparatus, where EGF-like repeat sequences undergo glycosylation modification during translocation. The Notch receptor then undergoes S1 cleavage in the Golgi to form a heterodimer and is transported to the cell membrane. In the presence of ubiquitin ligase, some Notch receptors on the cell membrane are endocytosed into the nuclear endosome, which has an acidic environment and contains ADAMs and γ-secretase. Notch receptors in endosomes have two fates, they can either be recirculated to the cell membrane and cleaved to the NICD (the E3 ubiquitin ligase Deltex acts as an activator of Notch, capable of upregulating Notch), or they are translocated to lysosomes for degradation. In signaling cells, the Notch ligand is inactive at the cell membrane, and after Neur or Mib ubiquitination, the ligand is activated and a Notch signaling cascade occurs (ligand–receptor binding indicated by bright red triangles). The ligand can then be endocytosed and the accompanying pulling force induces traction of the bound ligand and receptor toward the side of the signaling cell. In the absence of traction, the S2 site of the Notch receptor is masked by the NRR, and with increasing traction, the S2 cleavage site is exposed, allowing for a second cleavage to occur. ADAMs are indispensable for S2 cleavage. The product of Notch undergoing S2 cleavage is NEXT, which also has two fates, either remaining on the cell membrane and binding to γ-secretase to undergo a third cleavage (S3 cleavage) to produce the NICD, or endocytosis into the endosome and binding to γ-secretase on the membrane to undergo cleavage to produce either NICD or NEXT translocation to the lysosome for degradation. In total, there are three approaches to generate the NICD, which are classified as ligand-independent activation, ligand-dependent endocytosis-independent activation, and ligand-dependent endocytic activation. The resulting NICD can undergo phosphorylation modifications, leading to FBXW7-mediated NICD degradation. The NICD can translocate into the nucleus or remain in the cytoplasm to crosstalk with other signaling pathways such as NFκB, mTORC2, AKT, and Wnt. In the absence of the NICD, CSL binds to transcriptional repressors to inhibit the transcription of target genes. Once the NICD enters the nucleus, it can bind to CSL to recruit MAML, release transcriptional repressors, and recruit coactivators to promote the transcription of Notch target genes. The top right corner is the structural view of the ligand and the bottom left corner is the structural view of the receptor. NICD, Notch intracellular domain; ADAM, a disintegrin and metalloproteinase domain-containing protein; Neur, Neuralized; Mib, Mindbomb; NRR, negative regulatory region; NEXT, Notch extracellular truncation; CSL, Rbpj/Su(H)/Lag1; MAML, Mastermind-like proteins; TM, transmembrane domain; RAM, RBPJ association module; ANK, ankyrin repeats; PEST, proline/glutamic acid/serine/threonine-rich motifs; NLS, nuclear localization sequence; KyoT2/CIR/SHARP/SKIP/KDM5A, transcriptional repressor; EP300/MAML/PCAF/GCN5, transcription activator